SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Addex Therapeutics Partner to Initiate Phase 2 Clinical Trial of ADX71149 for the Treatment of Major Depressive Disorder With Anxiety Symptoms